Brief: Lee's Pharmaceutical Holdings Updates On An Investigational Gynecology Drug Product
15/01/2021 12:34
Jan 15 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* UPDATE ON AN INVESTIGATIONAL GYNECOLOGY DRUG PRODUCT
* UNIT HAS BEEN GRANTED CLINICAL TRIAL APPROVAL FROM NMPA TO
INITIATE PHASE III STUDY OF INTRAROSA
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0115/2021011501129.pdf
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA